More recently, IL-6 was shown to induce glioma stem cell (GSC) expansion via STAT3 signaling, as measured by CD133 expression, and implied by neurosphere formation, and enhanced growth of intracranial xenografts [57]. This evidence concerns the gene PROM1 and central nervous system cancer.